Open AccessWashout period for pregnancy post isotretinoin therapy
Author(s) -
Hina Jajoria,
Venkataram Mysore
Publication year - 2020
Publication title -
indian dermatology online journal
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/idoj.idoj_101_19
Subject(s) - medicine , isotretinoin , pregnancy , acne , clinical practice , drug , pharmacotherapy , pediatrics , obstetrics , intensive care medicine , gynecology , family medicine , dermatology , pharmacology , genetics , biology
Isotretinoin is an oral medication used for the treatment of severe acne unresponsive to other medications. This drug is teratogenic and should be prescribed with appropriate caution in selected group of patients. The washout period for pregnancy post isotrenoin therapy has always been a topic of controversy. Several guidelines have recommended a wash out period of one month if pregnancy is planned in a patient being administered with the drug.